HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

ERBB2 kinase domain mutation in the lung squamous cell carcinoma.

Abstract
Mounting evidence exists that the activation of proto-oncogene by somatic mutation plays an important roles in the development of human cancers. Recent reports revealed that the kinase domain of ERBB2 gene, a proto-oncogene, is somatically mutated in the lung adenocarcinomas, suggesting the mutated ERBB2 gene may act as an oncogene in human cancers. The purpose of this was to see whether the ERBB2 kinase domain is mutated in other lung cancer types besides the adenocarcinoma. Here, we performed mutational analysis of the ERBB2 kinase domain by polymerase chain reaction-single strand conformation polymorphism assay in 114 non-adenocarcinoma type non-small cell lung cancers (NSCLCs) tissue samples, including 100 squamous cell carcinomas, three adenosquamous carcinomas and 11 large cell carcinomas. We detected the ERBB2 kinase domain mutation in one squamous cell carcinoma (1.0%). The detected ERBB2 mutation showed G to C transversion at bp 2305 (2305G>C), which would result in the substitution of Asp to His at codon 769 (D769H). The amino acid D769 is located in the alpha-helix within the kinase domain, which is important in the binding of ATP with ERBB2. We simultaneously analyzed the somatic mutations of EGFR, K-RAS, PIK3CA and BRAF genes in the squamous cell carcinoma with the ERBB2 mutation, and found that the tumor did not harbor any EGFR or ERBB2 or K-RAS or PIK3CA or BRAF gene mutation, either. This study demonstrated that in addition to lung adenocarcinoma ERBB2 kinase domain mutation could occur in lung squamous cell carcinomas, and suggested that alterations of ERBB2-mediated signaling pathway by ERBB2 mutations may occasionally contribute to the development of lung squamous cell carcinomas.
AuthorsJong Woo Lee, Young Hwa Soung, Su Young Kim, Suk Woo Nam, Won Sang Park, Young Pil Wang, Keon Hyun Jo, Seok Whan Moon, Sang Yong Song, Jung Young Lee, Nam Jin Yoo, Sug Hyung Lee
JournalCancer letters (Cancer Lett) Vol. 237 Issue 1 Pg. 89-94 (Jun 08 2006) ISSN: 0304-3835 [Print] Ireland
PMID16029927 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • MAS1 protein, human
  • Proto-Oncogene Mas
  • Receptor, ErbB-2
Topics
  • Adult
  • Aged
  • Carcinoma, Adenosquamous (genetics)
  • Carcinoma, Large Cell (genetics)
  • Carcinoma, Non-Small-Cell Lung (genetics)
  • Carcinoma, Squamous Cell (genetics)
  • DNA Mutational Analysis
  • Female
  • Gene Expression Regulation, Neoplastic
  • Humans
  • Lung Neoplasms (genetics)
  • Male
  • Middle Aged
  • Mutation
  • Polymorphism, Single-Stranded Conformational
  • Protein Structure, Tertiary
  • Proto-Oncogene Mas
  • Receptor, ErbB-2 (chemistry, genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: